Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
16 February 2024 - 5:15AM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
From Feb 2024 to Feb 2025
